ClinicalTrials.govpublic full text
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
cognitive disorders, suvn-d4010, serotonin 4 (5-ht4) receptor, first in human, safety, pharmacokinetics, tolerability, single dose, repeat dose, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802964
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.